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Abbreviations  
          
 
 ACP Amphormous Calcium Phosphate 
AMG Amelogenin 
cDNA Complementary DNA 
D or Asp Aspartic acid 
DLS Dynamic light scattering 
E or Glu Glutamic acid 
ECM      Extracellular matrix  
EDTA Ethylenediaminetetraacetic acid 
EMP   Extracellular matrix protein 
HAc Acetic acid 
HAP Hydroxyapatite 
KLK4 Kallikrein-4   
MMP-20 Metalloprotenaise-20  
PdI Polydiversity index 
RH  Hydrodynamic radius 
rH Recombinant human 
SAXS Small-angle x-ray scattering 
TRAP Tyrosine- rich amelogenin peptide 
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1.  Abstract 
Amelogenin is an extracellular matrix protein which has an important role to play in 
enamel formation during tooth development. The need for amelogenin for research 
purposes in order to be utilized for its many potential applications have resulted in the 
rise of the production of recombinant amelogenin. So far, the most optimal expression 
system used for the production of recombinant amelogenin is Escherichia coli. The 
only difference between native amelogenin and recombinant amelogenin expressed 
using E.coli is that the latter lack methionine at the N-terminus and phosphate on 
Serine-16.The aim of this study was to produce recombinant amelogenin 
phosphorylation mimics and to investigate the effects of phosphorylation on 
amelogenin. A total of 16 recombinant amelogenin phosphorylation mimics were 
successfully constructed by site-directed mutagenesis where serine-16 was mutated to 
either aspartic acid or glutamic acid. There were difficulties encountered during the 
purification of the higher positively charged recombinant amelogenin phosphorylation 
mimics which indicated that factors other than optical density may have a vital effect 
on their production. No effect of phosphorylation was found on solubility as the 
phosphorylated amelogenins shared similar solubility profiles to their non-
phosphorylated analogues on the pH range of 4 to 8. The solubility of the recombinant 
amelogenin fusion and phosphorylation mimics were greater than that of the 
recombinant native amelogenin and its phosphorylation mimic analogue. The analysis 
of the recombinant amelogenin phosphorylation mimics by dynamic light scattering 
showed that they too can form nanospheres. There were minor variations in 
hydrodynamic radii and polydispersity indices of the recombinant phosphorylated and 
non-phosphorylated amelogenins at both 20
o
C and 37
o
C which indicated that 
phosphorylation had not affected amelogenin self-assembly. It was found that the 
recombinant amelogenin phosphorylation mimics as well as their non-phosphorylated 
analogues had similar strong apatite-binding affinity which also showed no effect of 
phosphorylation on the binding affinity of amelogenin. 
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2. Introduction 
Amelogenin is an extracellular enamel matrix protein (EMP) involved in 
biomineralization of the enamel which is the hardest tissue of the human body. 
Amelogenin, both in the native and recombinant form can be used for numerous 
applications such as periodontology, wound healing, bone formation and regeneration, 
implantology and endodontics (Lyngstadaas et al., 2009). Another interesting trait is 
that recombinant amelogenin can be easily modified and also purified based on its 
solubility properties with little use of chemicals (Bonde et al., 2012). Bonde et al. 
showed that amelogenin can be used as a purification tag for production of other 
proteins by using the same method used for amelogenin purification. This shows great 
potential for amelogenin in biomedical/ biotechnological applications. 
Several expression systems have been used in attempt to produce recombinant 
amelogenin with great similarity to the native protein. However, Escherichia coli 
expression system has provided most promising results in which extra amino acids are 
not added. In contrast to its native analogue, recombinant amelogenin expressed using 
E.coli lack methionine at the N-terminus and phosphate on Serine-16 (Simmer et al., 
1994). This was first reported by Simmer et al. in 1994; it was reported that murine 
cDNA encoding M180 was cloned and expressed in E.coli which resulted in the 
production of rM179. The loss of N-terminal methionine and phosphorylation on 
Serine-16 was suggested to be as a consequence of E.coli aminopeptidase. So far, 
there have been no reported adverse effects caused by the loss.  
This present study aims to produce recombinant amelogenin phosphorylaton mimics 
and to investigate the effects of phosphorylation of amelogenin on its properties. 
Therefore, site-directed mutagenesis of Serine-16 to aspartic acid (Asp, D) or 
glutamic acid (Glu, E) was performed in order to promote negative charges and to 
mimic the effect of the phosphorylated serine in the native amelogenin. The 
mutagenesis was carried on eight recombinant amelogenin constructs which were (i) 
rH174, (ii) rH163, (iii) rH146 (iv) rH174+3, (v) rH174+6, (vi) rH174+9, (vii) 
rH174+12, and (viii) rH174+15 in order to produce recombinant amelogenin 
phosphorylation mimics (Table 1).  
The primary recombinant human protein, rH174, used in this study is expressed from 
a gene encoding a 175 amino acid long amelogenin of which the N-terminal 
methionine is cleaved off during its expression in E.coli cells. In vivo amelogenin is 
proteolytically degraded by proteinase to form amelogenin cleavage products. In this 
study, the recombinant cleavage product equivalents used were rH146 and rH163.  
The recombinant amelogenin fusion proteins (rH174+3, rH174+6, rH174+9, 
rH174+12 and rH174+15) are a combination of rH174 and protein fusion tag added to 
the C- terminal end of the protein. The tag is comprised of the protein sequence 
KTKR (Lys-Thr-Lys-Arg) of which three of the amino acids are positively charged 
and hydrophilic (Lys and Arg).Thus, the addition of one tag to the C-terminal end will 
create an extra three positive charges. Following mutation, cultivation and 
purification, various properties of several of the recombinant amelogenins were 
characterized in order to investigate the effect of the phosphorylation on amelogenin. 
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2.1 Amelogenesis  
Amelogenesis is the process during tooth development where the enamel is formed in 
the extracellular enamel matrix (ECM) (Fincham et al., 1999). The mature enamel is 
composed primarily over ninety-five percent of an organic content that is carbonated 
hydroxyapatite (HAP) and negligible amounts of matrix protein. The mature enamel 
is composed of long, narrow calcium  HAP crystals with a length of about 100 µm 
and a width and thickness of about 70 x 30 nm (Daculsi et al.,1978 & 1984).These 
crystals are packed into parallel arrays referred to as enamel rods with a diameter of 
about 5 µm. The rods are separated by interrod enamel which is also composed of 
HAP intersecting with the enamel rods at 60
 o (
Simmer et al., 1995). 
The ECM contains enamel matrix proteins, such as amelogenin, non-amelogenin 
proteins and inorganic ions (e.g. Ca
2+
, PO
4-) 
necessary for enamel formation. During 
amelogenesis, amelogenin is secreted from oral epithelium cells called ameloblasts, to 
regulate the growth of hydroxyapatite crystals of the enamel. 90 % of the organic 
content of the developing ECM contains amelogenin and the remaining 10 % are non-
amelogenin proteins (Fincham et al., 1999). The ameloblasts also express and secrete 
other enamel extracellular protein e.g. metalloprotenaise-20 (MMP-20, also known as 
enamelysin) and kallikrein-4 (KLK4, also known as enamel matrix serine protease 1, 
EMSP1 (Simmer et al., 1998; Fincham et al., 1999; Hu et al., 2002).  
During the early secretory stage of enamel formation, long, thin ribbons of enamel 
minerals are formed shortly after the secretion of EMP by the ameloblasts (Smith, 
1998). During enamel formation, amelogenin is gradually digested by proteolytic 
enzymes resulting in the formation of mature enamel. The proteolytic degradation is 
carried out by MMP-20 which is expressed during the secretory stage of' enamel 
formation (Barlett et al., 1998) and KLK4 which is expressed during the maturation 
stage in the late stage of the enamel formation (Hu et al., 2002). MMP-20 initiates the 
breakdown whereas KLK4 completes the degradation process hence  completely 
removing amelogenin from the enamel matrix (Simmer and Hu, 2002).During the 
maturation stage, the EMP are almost completely removed and the mineral ribbons 
thicken and widen to form the enamel (Smith, 1998).  
2.2 Structure of Amelogenin 
In vivo amelogenin polypeptides can have a mass from 5 to 25 kDa which are 
produced as a result of proteolytic degradations, alternative splicing and due to the 
localization of two distinct single copy of the gene on either X or Y chromosome (Lau 
et al. 1992; Ribeiro do Espírito Santo et al., 2005). The human amelogenin gene 
consists of seven exons and most of the proteins formed originate from the X 
chromosome such as HX 175. Amelogenin and its cleavage products consist of 
mainly of proline (25%), glutamine (14%), leucine (9%) and histidine (7%). 
Amelogenin has three domains which are as follows: (1) a 45 amino acids long 
tyrosine rich N-terminal hydrophobic domain (TRAP) (2) a hydrophobic central 
region which mainly consists of Xxx- Yyy- Pro repetitive motifs and (3) an 11 amino 
acids long C-terminal hydrophilic domain (Fincham et al., 1999; Toyosawa et al., 
1998; Margolis et al., 2006). The primary structure of the N and C terminal ends are 
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highly conserved among species but there exist variations in the middle section which 
are primarily deletions and insertions of Xxx-Yyy-Pro (Brooks et al., 1994).  
Although the three-dimensional structure of amelogenin has not been determined, 
numerous techniques have been used to provide vital data on the structure of 
amelogenin. Numerous studies have shown that secondary structures of amelogenin 
consist of a large fraction of β sheets, turns and random coils whereas minor fraction 
is of α-helix (Zhang et al., 2011; Margolis et al., 2006). The N-terminus consists 
primarily of β sheets; the mid-section is rich in polyproline II and β turns such as β 
spirals and the C-terminus consist of random coils (Goto et al., 1993; Matsushima et 
al., 1998). 
2.3 Characteristics of Amelogenin 
2.3.1 Solubility of Amelogenin 
Amelogenin has low solubility at physiological pH around 7 which may be accounted 
for by its tendency to form nanospheres in vivo. However, the solubility is higher at 
weak acidic and alkaline pH (Tan et al., 1998 (b)). Several of amelogenin cleavage 
products have been studied and it was found that the removal of hydrophilic C- 
terminus causes the solubility of amelogenin to be lower under alkaline conditions 
than when the C terminus is present (Tan et al., 1998). In general, the solubility of 
amelogenin cleavage products are very high at acidic pH but TRAP exhibited an 
exception; instead, TRAP has low solubility from pH 4 to 9 (Tan et al., 1998(a)).  
Furthermore, the results in Tan et al., 1998 (b) showed native phosphorylated 
amelogenin and non-phosphorylated amelogenin have a difference in solubility. More 
specifically, the phosphorylated amelogenin has a lower solubility in alkaline pH in 
comparison to the phosphorylated amelogenin. 
2.3.2 Biomineralization 
In vitro studies have been carried out using HAP to investigate the interaction 
between amelogenin with enamel crystals. These studies have shown that the 
nanospheres provide a well-organized structure to modulate the formation of enamel 
apatite crystals (Lyngstadaas et al., 2009; Lyngstadaas et al., 1995). An early study by 
Aoba et al., 1987 has showed that the full-length intact amelogenin has a higher 
affinity for HAP than the proteolytically degraded amelogenin fragments. Likewise, a 
similar finding has also been reported by Moradian-Oldak et al., 2002 for recombinant 
amelogenin. More specifically, Bouropoulos et al., 2003 reported that full-length 
amelogenin nanospheres adsorb unto the apatite crystals’ surfaces as binding units 
with specific adsorption sites. Amelogenin covers 64% of the total area unit of the 
apatite binding surface which supports the hypothesis that amelogenin selectively 
bind to certain sites on the apatite surface. Additionally, Moradian-Oldak et al., 2002 
reported that the removal of the C-terminal of amelogenin has been shown to decrease 
amelogenin HAP binding affinity (Moradian-Oldak et al., 2002). 
Wiedemann-Bidlack et al., 2011 has found that phosphorylation of amelogenin has a 
vital impact on calcium phosphate formation in vitro. Unlike the non-phosphorylated 
analogue, the phosphorylated full-length amelogenin was able to stabilize 
amphormous calcium phosphate (ACP) for long period time before its transformation 
9 | P a g e  
 
to HAP crystals (Kwak et al., 2009; Wiedemann-Bidlack et al., 2011). This finding is 
noteworthy because studies have found that during enamel formation ACP is the first 
mineral phase formed that subsequently transforms to apatite crystals (Beniash et al., 
2009). In contrast, a recombinant amelogenin cleavage product had no effect on 
calcium phosphate. However, when a phosphorylated analogue of the cleavage 
product was used, ACP was stabilized for 24 hours but still did not transform to HAP 
(Kwak et al., 2009; Wiedemann-Bidlack et al., 2011).Therefore, these findings 
collectively show that phosphorylation of full length amelogenin has an important 
role to play in biomineralization. 
2.3.3 Self-assembly of amelogenin molecules  
Self–assembly which is a common property of extracellular organic matrix molecules 
is the process by which components of a system assemble together to form a larger 
functional unit which is facilitated by specific intermolecular interactions. 
Amelogenin self- assembly plays an important role in regulation of the growth and 
organization of the enamel. There are two hypothetical models to describe amelogenin 
self-assembly. More specifically, these models describe amelogenin as having the 
ability to self-assemble into either nanospheres or nanoribbons. These models are 
described below. 
Amelogenin Nanospheres Formation 
Amelogenin self-assembles into hydrophobic supramolecular aggregates, referred to 
as nanospheres that form an insoluble extracellular matrix (Eastoe, 1979, Fincham et 
al., 1994). A study by Aichmayer et al., 2005 which used a combined approach of 
DLS and SAXS (small-angle x-ray scattering) to investigate amelogenin self-
assembly proposed that nanospheres possess dense hydrophobic cores surrounded by 
loose shells comprised of negatively charged hydrophilic C-terminus that is exposed 
to the aqueous surrounding. It has also been suggested that nanospheres can interact 
via their C-terminus to agglomerate in order to form high order chain-like structures 
(Aichmayer et al., 2005). A more recent study by Aichmayer et al., 2010 showed that 
amelogenins deviate from the spherical nanopaticles and forms instead oblate 
nanoparticles. 
A study by Wiedemann-Bidlack et al., 2011 has proven that phosphorylated full 
length amelogenin can form high-order aggregate structures similar to its non-
phosphorylated analogue under physiological conditions of ionic strength (165 mM) 
and temperature (37
o
C). It was found that phosphorylation had a small but potentially 
vital effect on the pH at which the amelogenin begin to form high-order structures. 
This importance is linked to the fact that high-order amelogenin self-assembly is 
sensitive to pH. Studies have shown that generally amelogenin tend to form high-
order protein assemblies at pH levels near their respective isoelectric points 
(Wiedemann-Bidlack et al., 2011, He at al., 2008).  It is also important to note that 
Tan et al. 1998 (b) found that amelogenins tend to have the lowest solubility near their 
isoelectric point. 
Studies have shown that both N- and C- terminal are important for amelogenin self 
assembly (Paine et al., 2003). The removal of either N- or C- terminal ends affect 
amelogenin nanosphere formation which in turn results in a defective structural 
organization of the enamel. The amelogenin cleavage products lacking the 
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hydrophilic C-teminal form larger and less ordered agglomerates than full length 
amelogenin at higher pH levels of around 7.6-7.7 (Wiedemann-Bidlack et al., 2011; 
Wiedemann-Bidlack et al., 2007). These findings showed that the hydrophilic C-
terminus of both native and recombinant amelogenin plays an important role in the 
formation of higher-order chain-like assemblies, as was found in previous studies 
(Aichmayer et al., 2005; Moradian-Oldak et al., 2006). 
Dynamic Light scattering (DLS) was used in this study to investigate the effect of 
phosphorylation on amelogenin self-assembly under two temperatures at a constant 
pH. DLS measures the size of the aggregate particles in solution that is reported as 
hydrodynamic radii (RH) which is the mean particle size and polydispersity (PdI) 
which is based on the standard deviation around that mean. 
Amelogenin Nanoribbons Formation  
 Studies carried out by Martinez-Alva et al. have shown that amelogenins can form 
nanoribbons which are facilitated by the interaction of their hydrophobic N-termini 
(Martinez-Avila et al. 2011 & 2012). The assemblies of nanoribbons are formed by 
gradually combining and elongating together to form bundles structurally similar to 
the mineral crystallites in mature enamel. The amelogenin molecules combine 
together in anti-parallel arrangement with the hydrophilic C-terminus oriented 
towards the ribbon edges. Thus, these arrangements result in the accumulation of 
electrostatic charges at the edges which give rise to electrostatic repulsion of 
amelogenin nanoribbons and in turn, cause their parallel arrangement into bundles. 
However, self-alignment of the dimers was not observed for amelogenin lacking the 
hydrophilic C-terminus. 
Martinez-Alva et al., 2012 also showed that amelogenin nanoribbon formations are 
affected by pH, presence of calcium and phosphate ions and amelogenin 
concentration. It was evident that ribbons were able to form between pH 4.0 to 6.0 but 
were not formed at a pH below 4.0 (Martinez-Avila et al. 2012). However, pH above 
6.0 resulted in large amount of calcium phosphate mineral which obscured the 
observation of amelogenin structures formed. Therefore, there have been no 
conclusive experimental results which indicate that nanoribbons are formed above a 
pH level of 6.0.  
In addition, it was found that the presence of both calcium and phosphate ions 
resulted in the instability and disintegration of amelogenin nanospheres but 
simultaneously the growth of amelogenin nanoribbons within several days (Martinez-
Avila et al. 2012). When the mineral ions were added individually, there were no 
nanoribbons but the formation of nanospheres were promoted. Furthermore, exposure 
of EDTA to amelogenin ribbons suspensions resulted in the disintegration of the 
ribbons but formation of nanospheres. This further supports that calcium is needed for 
the stability of amelogenin nanoribbon structure 
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2.3.4 Amyloid Fibril Formation 
Amyloid fibrils are ordered aggregates of proteins which organize themselves in a 
fibrillar structure (Nilsson, 2004). As previously described, studies have shown that 
amelogenin form filaments that adopt a β-structure (Goto et al., 1993; Matsushima et 
al., 1998). These structures are the same as those found in amyloid fibrils.  
Three criteria need to be satisfied by a protein which forms amyloid fibrils. These 
include: (i) green birefringence upon staining with Congo red, (ii) fibrillar 
morphology and (iii) β sheet secondary structure (Nilsson, 2004). The most common 
methods utilized to identify the presence of amyloid fibrils are Thioflavin T (ThT) 
fluorescence, Congo Red binding, transmission electron microscopy (TEM) and 
Fourier transform infrared spectroscopy (FTIR). In this study, we tested amyloid 
formation for amelogenin nanoribbons using ThT assay. This assay is not one of the 
criteria but it is relatively accepted as an indicator of the presence of amyloid. ThT 
assay functions by measuring the changes in fluorescence intensity upon binding with 
the amyloid fibrils and this enhanced fluorescence can be viewed by fluorescence 
microscopy or spectroscopy. 
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3.Materials and Methods 
3.1 Site Directed Mutagenesis of Amelogenin 
3.1.1 Expression  
Site-directed mutagenesis of amelogenin was performed by replacing serine-16 with 
either D or E in each of eight non-phosophorylated amelogenin constructs. A total of 
sixteen amelogenin phosphorylation mimics were produced by the mutation which are 
all considered as phosphorylated amelogenin in this study (Table 1).  
Table 1. Recombinant amelogenin phoshorylation mimics successfully produced by site-directed 
mutagenesis of serine-16 to aspartic acid and glutamic acid. 
Template  C-terminal Modification Mutation Mutant 
rH174  Ser16→Asp rH174D 
rH174  Ser16→Glu rH174E 
rH146  Ser16→Asp rH146D 
rH146  Ser16→Glu rH146E 
rH163  Ser16→Asp rH163D 
rH163  Ser16→Glu rH163E 
rH174+3 KTKR-fusion Ser16→Asp rH174+3D 
rH174+3 KTKR-fusion Ser16→Glu rH174+3E 
rH174+6 KTKRKTKR-fusion Ser16→Asp rH174+6D 
rH174+6 KTKRKTKR-fusion Ser16→Glu rH174+6E 
rH174+9 KTKRKTKRKTKR-fusion Ser16→Asp rH174+9D 
rH174+9 KTKRKTKRKTKR-fusion Ser16→Glu rH174+9E 
rH174+12 KTKRKTKRKTKRKTKR-fusion Ser16→Asp rH174+12D 
rH174+12 KTKRKTKRKTKRKTKR-fusion Ser16→Glu rH174+12E 
rH174+15 KTKRKTKRKTKRKTKRKTKR-fusion Ser16→Asp rH174+15D 
rH174+15 KTKRKTKRKTKRKTKRKTKR-fusion Ser16→Glu rH174+15E 
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The site-directed mutagenesis was performed using polymerase chain reaction 
(PCR).Two sets of primers were designed to mutate serine-16 to D or to E. The 
following primers were used: 
 
The annealing temperature of 62 °C was found by testing the designed primers using 
conventional PCR. For a single amino acid mutation, the 50 µl PCR reaction 
contained 0.5 µl of plasmid with rH174 gene (Bonde et al., 2012), 1µl of 2.5 units/µl 
Pfu DNA polymerase,  0.5 µl of 0.5 mM dNTP, 0.5 µl each of 1 µM forward and 
reverse primers,  42 µl of deionised water and 5µl of 1x PFU buffer. The PCR cycles 
were initiated at 95 °C for 5 minutes and followed by 16 amplifications cycles which 
consisted of 95 °C for 30 seconds, 62 °C for 30 seconds and 72 °C for 12 minutes. 
The final extension was done at 72 °C for 5 minutes. 
3.1.2 Transformation 
The PCR products were treated with 1 µl Dpn I at 37°C for one hour. An aliquot of 10 
µl PCR product was used to transform previously prepared E.coli TGI competent 
cells, by heat shock at 42 °C for 60 seconds. The cells were incubated at 37°C for 45 
minutes in LB medium. The transformed cells were spread on LB plate containing 
100 µg/ml ampicillin and incubated at 37 °C overnight. 
3.2 Colony Screening 
3.2.1 Colony PCR and Sanger DNA Sequencing  
The purpose of colony PCR was to screen for plasmids harbouring the desired DNA 
insert in the plasmid constructs from the bacterial colonies. Colony PCR was 
performed in parallel to making master plates by streaking selected bacterial colony 
on an agar plate followed by rinsing the inoculation loop with the transformant in 
PCR reaction mix. Following PCR amplification, the PCR products are analyzed by 
agarose electrophoresis to select the positive colonies. The positive colonies were 
selected from the different constructs for plasmid purification and were verified by 
Sanger DNA sequencing. 
3.3 Cultivation and Expression 
Each construct was transformed into the expression host, E.coli BL21 (DE3).The 
expression host cells were inoculated in 10 ml LB-media supplemented with 200 
 ampicillin and were grown overnight in a shaking incubator at 37°C. These 
cultures were then used to inoculate TB-media supplemented with 200  
ampicillin, on the basis that, 100ml TB-medium should be inoculated with 0.5 ml 
overnight culture of OD600 of 3. Once the cultivations reached an optical density of 
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1.8-2.0, the cultures were induced by adding IPTG to reach a final concentration of 1 
mM.  The cultivations were carried out overnight in a shaking incubator at 37°C and 
rotation speed of 150-170 rpm. 
3.4 Purification of Amelogenin- Constructs 
3.4.1 Acid/heat Treatment 
Cells cultivated for 24 h were harvested by centrifugation (5000g, 5 min) and  were 
washed with 150 mM NaCl followed by another centrifugation (5000g,5 min).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
The cell pellets were resuspended in 3% acetic acid (HAc), which was followed by 20 
minutes of heat treatment at 80 °C in a water bath. The cell suspension were 
centrifuged (20 000 g, 40 min) and the supernatants containing soluble amelogenin 
were collected. The supernatants were dialyzed against 0.05% HAc.The dialyzed 
amelogenin samples were sterile filtered and aliquoted into 1.5 ml cryotubes. All 
recombinant amelogenin variants were lyophilized for proper storage. 
3.5 Amelogenin Concentration 
The total protein concentrations were determined by using Bradford assay (1ml 
Bradford reagent which was diluted 5x and 10 µl protein sample). The protein 
standard curve was made using 50 mg/ml rH174 which was diluted to concentration 
of 1.0, 0.75, 0.50 and 0.25 mg/ml. 
3.6 Characterization of Amelogenin Constructs  
A few of the amelogenin variants were chosen for characterization. These included: 
(i) rH174, (ii) rH174D, (iii) rH174+3, (iv) rH174+6, (v) rH174+9, (vi) rH174+9D, 
(vii) rH174+9E, (ix) rH174+12, (x) rH174+12D, (xi) rH174+15 and (xii) rH174+15D. 
The properties of the aforementioned phosphorylated (ii, vi, vii, x, xii) and non-
phosphorylated ( i, iii, iv, ix, xi) amelogenins were compared to evaluate the effects of 
phosphorylation on amelogenin properties. 
3.6.1 SDS-PAGE 
During the cultivation and acid/heat purification, samples were collected from the 
uninduced cells (500 µL), induced overnight culture (250 µL) and the amelogenin 
supernatant (50 µL). The OD600 of the induced cells and overnight cultures were 
measured in order to calculate the amount of SDS-loading buffer necessary for 
resuspension. The cells were harvested by centrifugation (8000 rpm, 1 minute). 
Subsequently, the cell pellets were resuspended in SDS-loading buffer to acquire a 
cell density equal to an OD600 of 10. In addition, the lyophilized proteins were also 
analyzed by SDS-PAGE. The lyophilized proteins were first dissolved in 0.05% HAc 
by incubating them in ice for three days. Prior to analysis on a 4-20 % SDS-PAGE 
gel, the samples were first boiled for 5 minutes. 
3.6.2 Solubility Test 
Solubility was tested in the presence and/or absence of either calcium and/or 
phosphate at pH range of 4-8. Amelogenin solutions were prepared by dissolving 
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lyophilized proteins (10 mg) in 0.05% HAc to a final concentration of 50 mg/ml   and 
then incubated overnight on ice at 4 °C. Buffer stock solutions with a concentration of 
100 mM were prepared at pH4 and pH5 using HAc, pH6 using MES and pH 7 and 8 
using HEPES. Calcium and phosphate stock solutions were prepared using CaCl2 and 
KH2PO4 to a concentration of 3M each, which in turn, were diluted to final 
concentration of 33.4 mM and 20.9 mM respectively using the  buffers at various pH. 
Mixtures of a total volume 75µl were prepared by adding 33.8 µl of diluted calcium 
or phosphate buffer solutions and/or buffer to 7.5 µl of amelogenin, followed by three 
days of incubation at 37 °C. The mixtures were centrifuged (13 000 rpm, 4 min) and 
the protein concentration of the supernatant was measured at 280 nm using sub-
microliter cuvette (Implen). 
3.6.3 Dynamic Light Scattering (DLS) 
 Amelogenin solutions were prepared as previously described above. Amelogenin 
samples were further diluted to a final concentration of 0.5 mg/ml using PBS buffer 
(pH 7.4) and water. A pH of 7.4 was chosen for this study because it corresponds 
closely to the pH found for the enamel fluid phase at the secretory stage (Aoba and 
Moreno, 1987). The samples were centrifuged for 3 minutes at 13000 rpm and then 
incubated at 37 °C for 4 hours. After 4 hours of incubation, DLS measurements were 
made. Subsequently, the amelogenin samples were incubated at 20 °C. The particle 
size measurements of the amelogenin constructs were carried out both at 37 °C and 20 
°C using Zeta Nano S (Malvern Instruments Ltd, England). 
3.6.4 Adsorption of Amelogenin onto Hydroxyapatite 
Calcium hydroxyapatite (HAP) stock suspensions were equilibrated in PBS to final 
concentrations of 50 and 25 mg/ml. To obtain the HAP crystals, the stock suspensions 
were centrifuged and supernatant were discarded. Amelogenin (1mg/ml in PBS) were 
mixed with the HAP crystals. Samples were collected at various times and centrifuged 
to obtain the supernatant for analysis. The protein concentrations were measured 
using Bradford assay. 
3.6.5 Amyloid Formation in Amelogenin Nanoribbons 
Amyloid formation was studied in the presence and/or absence of either calcium or 
phosphate at pH 5. The protein stock was prepared by solubilising lyophilized 
amelogenin in 10mM HCL to a final concentration of 50 mg/ml. The 100 µl protein 
assembly sample was prepared by adding the components in the following order 
2mg/ml amelogenin stock solution, deionised water, 20.9 mM potassium dihydrogen 
phosphate, 100 mM HAc (pH 5), 33.4 mM calcium chloride and 0.4 mM potassium 
hydroxide (KOH).The protein assembly samples were incubated at 37°C and 10 µl 
samples for testing were taken at various times (1h, 4h, 18h, 2 days and 3 days). The 
stock solution of thioflavin T (ThT) was prepared as described by Nilsson 2004. On 
the day of fluorescence measurement, the ThT was diluted 50, 25, 10, 5 times. Ten µl 
of amelogenin protein assembly sample and 90 µl ThT were mixed in a cuvette for the 
analysis. The fluorescence intensity was measured by excitation at 440 nm and 
emission 460 nm to 520 nm. 
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4.Results 
4.1 Site-Directed Mutagenesis 
In this study, a total of 16 novel recombinant amelogenin proteins were constructed 
which we refer to them as recombinant amelogenin phosphorylaton mimics. Two 
recombinant native amelogenin phosphorylation mimics, four recombinant 
amelogenin cleavage product phosphorylation mimics and ten recombinant 
amelogenin fusion phosphorylation mimics were produced from the site-directed 
mutageneses which are listed in table 1. 
To check whether site-directed mutagenesis was successful, agarose electrophoresis 
was used to analyze a few of the PCR products. It can be observed from the agorose 
gel that there were distinct bands in each lane which indicated that the amelogenin 
gene is present (data not shown).All sequences of the constructs were compared to the 
expected sequence using sequence alignment in order to  verify that two sequences 
are the same. The results showed that all the sequences matched the expected target 
sequences which mean that the mutation was successful. 
4.2 Expression and Purification 
Due to the numerous numbers of recombinant amelogenins, a few amelogenin 
constructs were chosen for larger scale production and characterization. All the 
amelogenin constructs migrated appropriately to their size (Fig.2). For the first 
cultivation, it can be seen from figure 2 that all the amelogenin constructs were 
expressed at induction optical density between 1.5-1.8. The band showing expression 
of rH174+15 was the most distinct with little impurities in comparison to the other 
amelogenin constructs. Although all the proteins were expressed, rH174+15 as well as 
rH174+15D produced no protein after purification in comparison to the remaining 
amelogenin constructs.  The amelogenin construct, rH174+9D, did not show a high 
yield in comparison to rH174D, rH174+6D and rH174+9E (Fig. 2). 
 
Figure 1. SDS-PAGE analysis of expression and purification of recombinant amelogenin constructs. Lane 
marked M is the protein molecular weight marker. Uninduced refers to before the addition of IPTG. 
Induced refers to after the addition of IPTG for induction. Purified AMG represents the amelogenin 
proteins after acid/heat treatment. 
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Due to low production of rH174+15 and rH174+15D amelogenin constructs, small 
scale cultivation was carried out for optimization of their production. To find out the 
optimal optical density for induction, the culture was induced at five different optical 
densities which are 1.0, 1.5, 2.0, 3.5 and 4.0. It was observed that rH174+15 and 
rH174+15D amelogenin constructs were expressed at induction optical densities of 
1.0 1.5 and 2.0 (Data not shown). However, at 1.0 and 1.5 protein expression was low 
in comparison to smaller amelogenin constructs (Fig.3); at 2.0, no proteins were 
expressed. 
 
Figure 2. SDS-PAGE analysis of purification of rH174+15 and rH174+15D amelogenin constructs. Lane 
marked M represent the protein molecular marker. Lanes marked 1.0 to 4.0 represent the induction optical 
densities tested. AMG stands for amelogenin. The two constructs were analyzed after their purification by 
acid/heat treatment. 
There was another cultivation done to verify the optimal induction optical densities 
for production of rH174+9D, rH174+15 and rH174 +15D. An additional recombinant 
amelogenin (rH174+12D) was tested. Surprisingly, rH174+15D, rH174+12D and 
rH174+15 were successfully induced at induction optical density ranging from 1.8 to 
2.0 but with a low yield (Fig.4A). It can be seen that an induction optical density 
range from 1.4 to 1.8 is suitable for the cultivation of rH174+9D (Fig 4B). This 
observation suggested that there might be other factors that play vital role in the 
cultivation of more positively charged recombinant amelogenin. 
 
Figure 3 .SDS-PAGE of (A). rH174+12D, rH174+15 and rH174+15D (B). rH174+9D amelogenin constructs, 
following cultivation and purification. Lane marked M represents protein marker. UN represents 
uninduced. IN represents induced. PA represents purified amelogenin by acid/heat treatment. Number 1 
represents OD600 1.790. Number 2 represent OD600 1.410. 
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To check the purity of the recombinant amelogenin constructs, lyophilized proteins 
were solubilised and were analyzed by SDS-PAGE. From figure 5, it can be seen that 
all the selected recombinant amelogenins for characterization were purified 
successfully. However, there were minor bands both below and above the major 
protein bands for all the amelogenins except rH174 and rH174D (Fig 5). Furthermore, 
the presence of the minor bands became more prominent with increased positive 
charges of the recombinant amelogenin (Fig.5).  
 
Figure 4. SDS-PAGE analysis of the recombinant amelogenin variants following purification. Lane marked 
M represents protein molecular marker. Lane 2 represents rH174. Lane 3, 6, 7, 10 and 12 represents 
amelogenin phosphorylation mimics. Lane 4,5,8,9 and 11 represents amelogenin fusion proteins. 
4.3 Solubility Profiles 
The purpose of the solubility test was to test the effect of the mutation on the 
solubility of amelogenin. A comparison of the solubility profile of several 
recombinant amelogenins over the pH range of 4 to 8 in the presence and absence of 
either calcium or phosphate ions was carried out in order to study the effect of the 
phosphorylation on amelogenin solubility. Although, the data on solubility of 
amelogenin was difficult to interpret, yet, efforts were made to draw out some points. 
The highest solubility for rH174 and rH174D were apparent when the pH was acidic, 
around 4 to 5 (Fig.6A & B). The solubility of rH174 and rH174D were lowest when 
the pH was close to neutral (Fig.6A & B). As the pH increased to alkaline, the 
solubility increased but it was still lower than that of acidic conditions ((Fig.6A & B). 
Thus, based on the results, it was found that the amelogenin, rH174 and rH174D 
shared similar solubility profiles. 
The solubility of rH174+9, rH174+9D and rH174+9E remained relatively higher than 
that of the rH174 and rH174D at all pHs (Fig.6 C, D & E) and four mineral conditions 
(Fig.7). The solubility curves of rH174+9, rH174+9E and rH174+9D  all tend to 
fluctuate slightly over pH range of 4-8 (Fig. 7).Thus, there were no significant 
differences between the solubility profile of the phosphorylation and non-
phosphorylation amelogenins of rH174+9 (Fig.6) for all the conditions tested.  
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Figure 5. Solubility of recombinant amelogenin proteins at 
various pH in the presence of calcium (Ca 2+, blue), 
presence of phosphate (PO4  , red), presence of both 
calcium and phosphate ( CaPO4, green) and in the absence 
of calcium and phosphate (Neg, purple). 
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Figure 7. Comparison between solubility profile of recombinant amelogenin in the (A) presence of calcium 
(B) presence of phosphate (C) presence of calcium and phosphate and (D) absence of calcium and 
phosphate. Orange, red, green, purple and blue colour represents the recombinant amelogenin proteins.  
 
 
 
 
 
 
Figure 6.Solubility profile of recombinant amelogenin 
proteins at various pH in the presence of calcium (Ca 2+, 
blue), presence of phosphate (PO4  , red), presence of both 
calcium and phosphate ( CaPO4, green) and in the 
absence of calcium and phosphate (Neg, purple). 
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4.4 DLS Analysis  
The hydrodynamic radius (RH) and polydispersity index (PdI) of the recombinant 
amelogenins were measured at temperatures of 20
o
C and 37
o
C at pH 7.4 in order to 
check the effect of phosphorylation on amelogenin self-assembly. There were small 
variations in RH   of each amelogenin variant when compared at 20
 o
C and 37 
o
C. The 
phosphorylated proteins of rH174 and rH174+9 had lower RH than their non-
phosphorylated analogues at both temperatures. On the contrary, the phosphorylated 
proteins of rH174+12 and rH174+15 had higher RH than their non-phosphorylated 
analogues (Table 2). 
Likewise, the PdI of the amelogenins did not show significant variation at both 
temperatures. All the amelogenins except for rH174+12D, rH174+15 and rH174+15D 
are considered to be monodisperse because they have PdIs close to 0.1. The 
amelogenins  constructs, rH174+12D, rH174+15 and rH174+15D, had very high PdIs 
which were close to 0.4 and significantly higher RH in comparison to the other 
amelogenins at temperatures of both 20
o
C and 37
o
C (Table 2). 
 
Table 2. The hydrodynamic radius (RH) and polydispersity index (PdI) of the recombinant amelogenin 
variants at 20oC and 37oC (pH7.4). 
 20
  0
C 37 
0
C 
Amelogenin 
Construct 
RH PdI RH PdI 
rH174 17.03 0.037 17.60 0.043 
rH174D 16.49 0.198 17.59 0.138 
rH174+3 17.28 0.034 18.92 0.114 
rH174+6 19.06 0.155 19.63 0.179 
rH174+9 17.65 0.053 18.0 0.067 
rH174+9D 16.12 0.108 18.47 0.158 
rH174+9E 16.16 0.093 18.09 0.082 
rH174+12 17.92 0.061 18.51 0.096 
rH174+12D 40.23 0.436 38.05 0.417 
rH174+15 26.58 0.387 27.41 0.377 
rH174+15D 40.76 0.485 41.37 0.477 
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4.5 Binding Affinity of Amelogenin to HAP 
The binding affinity of amelogenin to HAP was tested to investigate the difference in 
adsorption of phosphorylated and non-phosphorylated amelogenin unto HAP. 
Following the addition of HAP, the concentration of both rH174 and rH174D 
decreased sharply from 0 minutes until 1 minute.  From 1 minute onwards, 
amelogenin concentration remained fairly constant, that is, close to zero (Fig.8). This 
indicated that rH174 and rH174D share almost identical affinity to hydroxyapatite.  
 
Figure 8 . Binding Affinity Curves of recombinant amelogenin to HAP. The concentration of HAP 
equilibrated in PBS (pH7.4) was 50 mg/ml. 0 min represent the initial concentrations of amelogenin, without 
HAP. 
From the first binding affinity test it was observed that amelogenin was adsorbed 
quickly to HAP, thus, the concentration of HAP was changed from 50mg/ml to 25 
mg/ml in the subsequent tests. Similar to figure 8, the concentration of the 
recombinant amelogenins decreased sharply but to approximately 0.3 and/ or 0.4 
mg/ml for the first minute (fig. 9 & 10). Then, amelogenin concentration decreased 
steadily as it approached zero. There was no significant trend among the recombinant 
amelogenins that can be used to distinguish their affinity to adsorb HAP.  
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Figure 9. Binding Affinity Curves (A) Comparison between rH174 and the recombinant amelogenin fusion 
proteins (B) Comparison between rH174 and the recombinant amelogenin phosphorylation mimics. The 
initial concentration of HAP equilibrated in PBS (pH7.4) was 25 mg/ml. 0 h represent the initial 
concentration of amelogenin, without HAP. 
 
Figure 10. Binding Affinity Curves (A) & (B) Comparison between recombinant non-phosphorylated 
amelogenins to their phosphorylated analogue. The initial concentration of HAP equilibrated in PBS 
(pH7.4) was 25 mg/ml. 0 h represents the initial concentration of amelogenin, without HAP. 
 
4.6 Amyloid Formation in Amelogenin 
Nanoribbons 
The results for amelogenin amyloid formation test was not presented  here because 
the data was questionable. 
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5. Discussion  
Most importantly, the site-directed mutagenesis was successful as a total of sixteen 
recombinant amelogenin phosphorylation mimics were successfully constructed by 
mutating serine-16 to Asp and/or Glu (Table1). This was confirmed by the positive 
results obtained from sequence alignments of the amelogenins (data not shown). The 
recombinant amelogenin phosphorylation mimics are all considered to be 
phosphorylated amelogenin proteins. 
A few of the amelogenin constructs were selected for cultivation and characterization. 
Among the recombinant amelogenins cultivated for this study, rH174+9D, 
rH174+12D, rH174+15 and rH174+15D posed the most difficulty for their 
purification. The results for optimization experiments were inconclusive because an 
optimal induction optical density could not be found (Fig.2-4). This suggests that 
there might be other important factors that influence the cultivation yield of these 
amelogenin which may include number of positive charges of amelogenin, rotation 
speed and heat exposure.  It is noteworthy  that with increased positive charges, more 
minor bands can be seen on the SDS-PAGE picture (Fig. 5).These bands may be as a 
result of the presence of impurities from synthesis.   
It was found that the amelogenin mutants also form nanospheres. Previous studies (e.g 
Wiedemann-Bidlack et al. 2011) have shown that phosphorylated amelogenin can 
form nanospheres similar to non-phosphorylated analogues. Therefore the results 
obtained in this study seem to agree with previous results because there is a small 
difference between the RH and PdIs of phosphorylated and non-phosphorylated 
amelogenin analogues. Analysis of the data presented in Table 2 collectively show 
that temperature had little effect on the sizes and PdIs of the aggregates of amelogenin 
fusion and phosphorylation mimic proteins. Although there was a slight increase of 
RH of all the amelogenins except rH174+12D at the higher temperature of 37 
o
 C but 
no critical effect of temperature was observed. Likewise, the PdI also did not show 
any changes that can be considered as an effect of temperature. It is noteworthy that 
the high PdIs exhibited by rH174+12D, rH174+15 and rH174+15D may signify that 
these amelogenins are more prone to form heterogeneous aggregates or it simply 
might be the presence of contaminants in the samples.  
Amelogenin has been reported to adsorb unto HAP surfaces to guide the organization 
and shape of the enamel crystallites as they develop in the matrix (Bouropoulos et al, 
2003; Simmer et al, 1994). The decrease in amelogenin concentration (Fig. 8, 9 & 
10), signifies that the recombinant amelogenin variants bound to the HAP crystals 
which agrees with previous studies. Both the phosphorylated and non-phosphorylated 
amelogenin analogues seem to exhibit similar apatite-binding affinity (Fig. 8, 9 & 10). 
Thus, there were no major effects of phosphorylation found on binding affinity of 
amelogenin to HAP. In general, all the recombinant amelogenins had very strong 
binding affinity towards HAP.  
There was an initial rapid decrease of amelogenin concentration which most likely 
suggests that the recombinant amelogenins bound very quickly to the HAP crystals. 
This was followed by a gradual decrease in amelogenin concentration which probably 
indicates that all the amelogenin molecules in solution had bound to the HAP crystals 
up to their saturated point which reduced rate of reaction in the latter stage (Fig.8). A 
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small difference was observed in the curves when the concentrations of HAP crystals 
were decreased by half in which there was a slower rate of adsorption for 25mg/ml of 
HAP crystals (Fig 9 & 10). The higher concentration of HAP crystals (50 mg/ml) has 
a larger surface area than the lower concentration (25 mg/ml) which resulted in 
increased exposure of apatite binding sites for amelogenin. The increased exposure in 
turn increased the probability of amelogenin binding to its specific apatite face 
(Bouropoulos et al, 2003) which thus increased adsorption of HAP. 
There was much difficulty to interpret the results on solubility. The data on solubility 
could be more reliable if more replicas were done. The similarity of solubility curves 
between the phosphorylated and non-phosphorylated amelogenins indicated that there 
were no effects of phosphorylation on the solubility of amelogenin. The results of this 
present study on the solubility of rH174 and rH174D agrees with previous results that 
that describe amelogenin solubility to be highest in acidic conditions, low at 
physiological pH, and high again at basic pH (Tan et al., 1998). The similarity in the 
solubility profile of rH174 and rH174D (Fig. 6 A & B) also indicates that there is a 
great probability that rH174E has a similar solubility profile as rH174 and 
rH174D.The amelogenin fusion protein (rH174+9) and its phosphorylation mimics 
had higher solubility than rH174 and rH174D (Fig. 7) which indicate that similar 
findings may be true for the other amelogenins. Furthermore, unlike rH174 and 
rH174D, the solubility of rH174+9 and its phosphorylation analogues continuously 
fluctuate  over pH range 4 to 8 (Fig.7).These findings may be because the amelogenin 
fusion protein and the phosphorylation mimics have additional hydrophilic amino 
acids in comparison to rH174 making them less prone to aggregate.  
We wanted to develop a test that could readily check for the presence of various 
amelogenins based on their property of adopting β structure. Unfortunately, due to the 
results being inconclusive, the data of the experiment to check for β-amyloid 
formation in amelogenin nanoribbons were not presented in this study.  
The enamel is formed by highly orchestrated extracellular processes which involve 
enamel matrix proteins to regulate and organize the nucleation and growth of mineral 
crystals. Although substantial evidence suggests that protein-protein and protein -
mineral interactions play crucial roles in enamel formation and organization, yet, the 
precise mechanism by which this is done is not well understood. The results presented 
here could give us insight on the role that the properties of amelogenin play in the 
numerous potential applications of amelogenin. 
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6. Future Works  
It is important to note that there was difficulty in the interpretation of the results on 
solubility of the amelogenin variants. The results would have been easier to interpret 
and more reliable, had more replicates been used in the experimental work. Therefore, 
it is advisable to make several replicates for solubility tests in future studies. In 
addition, this study showed that amelogenin fusion protein and the phosphorylation 
mimics generally had higher solubility than rH174 in all conditions tested (Fig. 7). In 
addition, the solubility of the amelogenin fusion phosphorylation mimics fluctuated 
over the entire pH scale of 4-8.However in this study, only rH174+9, rH174+9D and 
rH174+9E were tested and thus it would be better if more investigations was done to 
include all the amelogenin proteins for more concrete results. 
Difficulties were encountered to successfully produce recombinant amelogenin 
rH174+15, rH174+15D and rH174+9D. An experiment was carried out for 
optimization of rH174+15, rH+15D and rH174+9D amelogenin constructs but the 
results were not definitive. Therefore, more experimental works need to be done to 
optimize the production and/or purification of all the recombinant amelogenin 
phosphorylation mimics and to verify the optimal conditions for production and 
purification and to check if the growth conditions are similar to recombinant fusion 
amelogenin. 
In this study, it showed that temperature had little effect on self-assembly of 
amelogenin fusion and phosphorylation mimic proteins. It was difficult to keep the 
amelogenin self-assembly samples at the set temperature because of handling of the 
samples after incubation. This may have possibly altered the structures formed by the 
amelogenin samples which could have led to more heterogeneous size distribution. It 
is vital that future experiments work to find a way to keep amelogenin self-assembly 
samples at the set temperature. 
Although from the experimental results it was obvious that the recombinant 
amelogenin variants have a strong binding affinity for HAP (Fig.8), more replicas 
should be carried out to investigate whether there are differences among the 
amelogenin binding affinities. The test should also be carried out under varying 
conditions (temperature, pH, apatite concentration and amelogenin concentration). 
Future testing should be done in an attempt to develop a test to check for amelogenin 
using amyloid formation as the basis. Both Congo red and ThT can be investigated in 
order to find which method can be more readily utilized for the test.  
As a consequence of lack of time and high numbers of recombinant amelogenin 
produced, it was not possible to investigate all the 16 amelogenin variants thoroughly 
in this study. Future studies should aim to compare and contrast various 
characteristics of all the amelogenin fusion protein to their phosphorylation mimics 
and to the native recombinant amelogenin.  
Generally in this study, the focus was more on performing many experiments to find 
the differences between phosphorylated and non-phosphorylated amelogenins through 
testing various properties of amelogenin. Thus, few replicas were used for all the 
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tests. Preferably, lesser tests and more replicates should have been done for this study 
in order to obtain more reliable results. 
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Popular Science Article  
The Effects of Phosphorylation of Amelogenin 
We use our teeth daily to eat all sorts of food with varying degrees of texture and 
hardness. The white part of our teeth called the enamel is the hardest tissue of the 
human body. Have you ever wondered what makes our teeth so hard and strong that 
we can chew on a chicken bone? Well, the answer is amelogenin which is the main 
subject of this study. Amelogenin is one of the many proteins that help build the 
enamel. However, amelogenin is of greatest importance to enamel formation because 
in its absence scientists have found that it leads to teeth defects.  
Scientists have also discovered that amelogenin can be utilized in many applications 
such as teeth defects, wound healing, bone formation and regeneration and many 
others. So far, there are two amelogenin-based products on the market. These 
products include (i) Emdogain® for the treatment of periodontitis, an enamel defect 
due to lack of proper amelogenin and (ii) Xelma® used to treat leg ulcers. As a result 
of the numerous potential applications of amelogenin, thus, there is increasingly more 
research carried out on amelogenins. 
So far, the most optimal production system used for the production of recombinant 
amelogenin is the bacteria called Escherichia coli. The only difference that existed 
between native amelogenin and recombinant amelogenin expressed using E.coli is 
that the latter lack the amino acid methionine at the N-terminus and phosphate group 
on Serine-16.The aim of this present study was to produce recombinant amelogenin 
phosphorylation mimics and to investigate the effects of phosphorylation of 
amelogenin on its properties. The properties of the novel phosphorylated amelogenin 
mimics with that of non-phosphorylated amelogenins were compared in order to 
examine the effects of the phosphorylation. 
In this study, a total of sixteen novel recombinant amelogenin phosphorylation 
mimics were successfully constructed by a type of mutation called site-directed 
mutagenesis. This mutation was carried out by replacing one amino acid into another 
amino acid in amelogenin amino acid sequence. More specifically, the amino acid, 
serine at sixteenth position was replaced with either glutamic acid or aspartic acid in 
the amelogenin sequence. The site-directed mutagenesis of Serine-16 to aspartic acid 
or glutamic acid was performed in order to promote negative charges and to mimic 
the effect of the phosphorylated serine in the native amelogenin. Since the two amino 
acids used are negatively charged, thus, it was thought that it could be used to 
substitute the negatively charged phosphate group. 
Various properties of amelogenin were tested to investigate the effect of 
phosphorylation on amelogenin. The study investigated how soluble recombinant 
amelogenin phosphorylation mimics are in acidic, neutral and alkaline solutions in 
presence of calcium and phosphate ions. Amelogenin usually change their shape and 
form spherical particles called nanospheres during enamel formation. Therefore, the 
radii of these particles and dispersity (how uniform the particles in the sample mixture 
are) were measured under neutral conditions and at temperatures of 20 and 37
o
C. The 
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interaction between the amelogenin and a substance called calcium hydroxyapatite 
that constitutes ninety-percent of the enamel was also tested. 
The phosphorylated amelogenins had similar solubilities to their non-phosphorylated 
amelogenins in acidic, neutral and alkaline conditions which indicated that 
phosphorylation had no effect on the solubility of amelogenin. The solubility of 
recombinant amelogenin phosphorylation mimics was greater than that of 
recombinant native amelogenin and its phosphorylation mimic counterpart. It was 
also found that the recombinant amelogenin phosphorylation mimics too can form 
nanospheres similar to the non-phosphorylated amelogenin. There were minor 
variations in radii and dispersity of the recombinant amelogenins at 20
o
C and 37
o
C 
which indicated that phosphorylation had not affected the amelogenins. Furthermore, 
temperature had no critical effect on radii and dispersity of amelogenin. The 
amelogenin phosphorylation mimics as well as their non-phosphorylated counterparts 
had a similar, strong interaction with calcium hydroxyapatite. 
Although in the study, no exceptional findings were found for the effects of 
phosphorylation on amelogenin but at least the recombinant amelogenin 
phosphorylation mimics function to some extent as the native recombinant 
amelogenins.  
